{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T23:46:24Z","timestamp":1782258384388,"version":"3.54.5"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6,23]]},"DOI":"10.7759\/cureus.111385","type":"journal-article","created":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T22:49:26Z","timestamp":1782254966000},"source":"Crossref","is-referenced-by-count":0,"title":["Chronic Kratom Use as a Potential Risk Factor for Embolic Stroke of Undetermined Source: A Case Report"],"prefix":"10.7759","author":[{"given":"Zhuo","family":"Luan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seunghong","family":"Rhee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paisith","family":"Piriyawat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy H","family":"Sim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1182\/hematology.2025000682","article-title":"Cryptogenic stroke: definitions and management","volume":"2025","author":"Powers WJ","year":"2025","unstructured":"Powers WJ. Cryptogenic stroke: definitions and management. Hematology Am Soc Hematol Educ Program. 2025, 2025:15-21. 10.1182\/hematology.2025000682","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3390\/medicina61071252","article-title":"Embolic stroke of undetermined source (ESUS): exploring the neurocardiological axis and its clinical implications","volume":"61","author":"Sargu GD","year":"2025","unstructured":"Sargu GD, Covali R, Filip C, et al.. Embolic stroke of undetermined source (ESUS): exploring the neurocardiological axis and its clinical implications. Medicina (Kaunas). 2025, 61:1252. 10.3390\/medicina61071252","journal-title":"Medicina (Kaunas)"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7511a1","article-title":"Increases in kratom-related reports to poison centers - National Poison Data System, United States, 2015-2025","volume":"75","author":"Towers EB","year":"2026","unstructured":"Towers EB, Thomas YT, Holstege CP, Farah R. Increases in kratom-related reports to poison centers - National Poison Data System, United States, 2015-2025. MMWR Morb Mortal Wkly Rep. 2026, 75:139-45. 10.15585\/mmwr.mm7511a1","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1403140","article-title":"Kratom safety and toxicology in the public health context: research needs to better inform regulation","volume":"15","author":"Henningfield JE","year":"2024","unstructured":"Henningfield JE, Grundmann O, Huestis MA, Smith KE. Kratom safety and toxicology in the public health context: research needs to better inform regulation. Front Pharmacol. 2024, 15:1403140. 10.3389\/fphar.2024.1403140","journal-title":"Front Pharmacol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s40122-020-00151-x","article-title":"Kratom-pharmacology, clinical implications, and outlook: a comprehensive review","volume":"9","author":"Eastlack SC","year":"2020","unstructured":"Eastlack SC, Cornett EM, Kaye AD. Kratom-pharmacology, clinical implications, and outlook: a comprehensive review. Pain Ther. 2020, 9:55-69. 10.1007\/s40122-020-00151-x","journal-title":"Pain Ther"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1080\/08998280.2017.11929647","article-title":"Posterior reversible leukoencephalopathy syndrome after kratom ingestion","volume":"30","author":"Castillo A","year":"2017","unstructured":"Castillo A, Payne JD, Nugent K. Posterior reversible leukoencephalopathy syndrome after kratom ingestion. Proc (Bayl Univ Med Cent). 2017, 30:355-7. 10.1080\/08998280.2017.11929647","journal-title":"Proc (Bayl Univ Med Cent)"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.726003","article-title":"The adverse cardiovascular effects and cardiotoxicity of kratom (Mitragyna speciosa Korth.): a comprehensive review","volume":"12","author":"Leong Bin Abdullah MF","year":"2021","unstructured":"Leong Bin Abdullah MF, Singh D. The adverse cardiovascular effects and cardiotoxicity of kratom (Mitragyna speciosa Korth.): a comprehensive review. Front Pharmacol. 2021, 12:726003. 10.3389\/fphar.2021.726003","journal-title":"Front Pharmacol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(13)70310-7","article-title":"Embolic strokes of undetermined source: the case for a new clinical construct","volume":"13","author":"Hart RG","year":"2014","unstructured":"Hart RG, Diener HC, Coutts SB, et al.. Embolic strokes of undetermined source: the case for a new clinical construct. Lancet Neurol. 2014, 13:429-38. 10.1016\/S1474-4422(13)70310-7","journal-title":"Lancet Neurol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.116134","article-title":"An insight review on the neuropharmacological effects, mechanisms of action, pharmacokinetics and toxicity of mitragynine","volume":"171","author":"Annuar NA","year":"2024","unstructured":"Annuar NA, Azlan UK, Mediani A, et al.. An insight review on the neuropharmacological effects, mechanisms of action, pharmacokinetics and toxicity of mitragynine. Biomed Pharmacother. 2024, 171:116134. 10.1016\/j.biopha.2024.116134","journal-title":"Biomed Pharmacother"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1021\/acscentsci.9b00141","article-title":"7-hydroxymitragynine is an active metabolite of mitragynine and a key mediator of its analgesic effects","volume":"5","author":"Kruegel AC","year":"2019","unstructured":"Kruegel AC, Uprety R, Grinnell SG, et al.. 7-hydroxymitragynine is an active metabolite of mitragynine and a key mediator of its analgesic effects. ACS Cent Sci. 2019, 5:992-1001. 10.1021\/acscentsci.9b00141","journal-title":"ACS Cent Sci"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/s0306-3623(00)00051-3","article-title":"Role of the postsynaptic alpha(2)-adrenergic receptor subtypes in catecholamine-induced vasoconstriction","volume":"34","author":"Duka I","year":"2000","unstructured":"Duka I, Gavras I, Johns C, et al.. Role of the postsynaptic alpha(2)-adrenergic receptor subtypes in catecholamine-induced vasoconstriction. Gen Pharmacol. 2000, 34:101-6. 10.1016\/s0306-3623(00)00051-3","journal-title":"Gen Pharmacol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-198631020-00004","article-title":"Serotonin and the vascular system. Role in health and disease, and implications for therapy","volume":"31","author":"Houston DS","year":"1986","unstructured":"Houston DS, Vanhoutte PM. Serotonin and the vascular system. Role in health and disease, and implications for therapy. Drugs. 1986, 31:149-63. 10.2165\/00003495-198631020-00004","journal-title":"Drugs"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.119.027272","article-title":"Carotid plaque with high-risk features in embolic stroke of undetermined source: systematic review and meta-analysis","volume":"51","author":"Kamtchum-Tatuene J","year":"2020","unstructured":"Kamtchum-Tatuene J, Wilman A, Saqqur M, Shuaib A, Jickling GC. Carotid plaque with high-risk features in embolic stroke of undetermined source: systematic review and meta-analysis. Stroke. 2020, 51:311-4. 10.1161\/STROKEAHA.119.027272","journal-title":"Stroke"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1007\/s11883-022-01006-w","article-title":"Inflammatory links between hypertriglyceridemia and atherogenesis","volume":"24","author":"Peng X","year":"2022","unstructured":"Peng X, Wu H. Inflammatory links between hypertriglyceridemia and atherogenesis. Curr Atheroscler Rep. 2022, 24:297-306. 10.1007\/s11883-022-01006-w","journal-title":"Curr Atheroscler Rep"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/488296-chronic-kratom-use-as-a-potential-risk-factor-for-embolic-stroke-of-undetermined-source-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T22:49:27Z","timestamp":1782254967000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/488296-chronic-kratom-use-as-a-potential-risk-factor-for-embolic-stroke-of-undetermined-source-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,23]]},"references-count":14,"URL":"https:\/\/doi.org\/10.7759\/cureus.111385","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6,23]]}}}